Spotlight on Memantine in Moderate to Severe Alzheimer's Disease†

By McKeage Kate  

Drugs & Aging, Vol. 27, Iss. 2, 2010-02 ,pp. : 177-179

Adis International

Access to resources Recommend Favorite

Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan

By Nakamura Yu   Kitamura Shin   Homma Akira   Shiosakai Kazuhito   Matsui Daiju  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 913-925

Informa Healthcare

Access to resources Recommend Favorite

A Systematic Review of the Clinical and Cost-Effectiveness of Memantine in Patients with Moderately Severe to Severe Alzheimer's Disease

By Kirby Joanna   Green Colin   Loveman Emma   Clegg Andrew   Picot Joanna   Takeda Andrea   Payne Elizabeth  

Drugs & Aging, Vol. 23, Iss. 3, 2006-01 ,pp. : 227-240

Adis International

Access to resources Recommend Favorite

Memantine: A Pharmacoeconomic Review of its Use in Moderate-to-Severe Alzheimer's Disease

By Plosker Greg L.   Lyseng-Williamson Katherine A.  

PharmacoEconomics, Vol. 23, Iss. 2, 2005-01 ,pp. : 193-206

Adis International

Access to resources Recommend Favorite

Is memantine a breakthrough in the treatment of moderate-to-severe Alzheimer’s disease?

By Doggrell Sheila  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 10, 2003-10 ,pp. : 1857-1860

Informa Healthcare

Access to resources Recommend Favorite